Thomas Eye Group Among the First in U.S. to Implant New Tecnic Symfony Intraocular Lenses

September 12, 2016 – Thomas Eye Group, a leading metro Atlanta eye care provider that offers comprehensive services including LASIK and medical, surgical and cosmetic eye care, announced today that it is among the first ophthalmology groups in the nation to implant the new Tecnis Symfony and Tecnis Symfony Toric lenses for cataract treatment. The recently FDA-approved lenses from Abbott Medical Optics are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, a condition that causes blurred or distorted vision.

“We have implanted traditional multifocal lenses for years, but they’re limited to improving near and distance vision,” said Dr. Leon R. Gross, Thomas Eye Group ophthalmologist specializing in cataract and lens-based surgery. “The new technology of IOL provides an extended range of vision that includes mid-range, allowing patients to clearly see their computer screens, read music or play sports like golf that require sharp near, mid-range and distance vision.”

The advanced IOL can solve the problem of glare and halos in low light situations such as driving or reading a book or restaurant menu and diminish reliance on contact lenses and eye glasses post surgery, providing patients with more options for their active lifestyles.

Cataracts, the clouding of the eye’s natural lens, affect more than 22 million Americans and that number is expected to climb to 30 million by the year 2020. Cataracts are also the most common cause of vision loss in people over age 40 and the principal cause of blindness in the world.

The surgery, which takes 15 minutes, involves replacing the damaged natural lens with an artificial lens and is meant to be a permanent solution. Vision in most patients returns within 24 hours and continues to improve during the next two to three weeks.

“It’s very important that we continually invest in the latest technologies,” said Rod Roeser, CEO for Thomas Eye Group. “The Tecnis Symfony lenses are yet another advancement that will allow our doctors to deliver the highest quality patient care available.”

Dr. Gross added, “With the offering of new advances in surgery, it’s important for patients to discuss their vision goals and lifestyle preferences with their surgeon to make the most informed decision about which treatment options are right for them.”

For more information on cataract surgery and its benefits, contact Thomas Eye Group at 678-892-2020 or visit www.thomaseye.com.